Cells, Volume 10, Issue 2
2021 February - 287 articles
Cover Story: Macrophage migration inhibitory factor (MIF) is a pleiotropic inflammatory cytokine, found to exert an anti-fibrotic effect in toxic liver injury by inhibiting hepatic stellate cell activation. Using genetically modified mouse models, we explored an unexpected pro-fibrogenic role of MIF in non-alcoholic steatohepatitis (NASH) and identified hepatocytes as a functional relevant source of MIF during NASH. Via further in vivo and in vitro analysis, we could evidence that MIF directly contributes to NKT polarization during NASH, shifting the balance toward the pro-fibrotic type I subtype. Complementing expression analysis studies in human liver samples with different NAFLD stages indicates that the role of MIF and the identified mechanisms are conserved between men and mice. The study adds an unidentified layer to the understanding of the complex role of MIF during chronic liver injury. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.